Deep Learning in Drug Discovery market Research Report by 2022, Forecast till 2035 The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost. This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning-based technologies / solutions within the healthcare industry. The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:  Therapeutic Area  Oncological Disorders  Infectious Diseases  Neurological Disorders  Immunological Disorders  Endocrine Disorders  Cardiovascular Disorders  Respiratory Disorders  Ophthalmic Disorders  Musculoskeletal Disorders  Inflammatory Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia Pacific  Rest of the World The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:  Aegicare  Aiforia Technologies  Ardigen  Berg  Google  Huawei  Merative  Nference  NVIDIA  Owkin  Phenomic AI  Pixel AI Table of Contents 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY 5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS 6. COMPANY PROFILES 7. PORTER’S FIVE FORCES ANALYSIS 8. CLINICAL TRIAL ANALYSIS 9. FUNDING AND INVESTMENT ANALYSIS 10. START-UP HEALTH INDEXING 11. COMPANY VALUATION ANALYSIS 12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY 13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS 14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS 15. CONCLUDING REMARKS 16. INTERVIEW TRANSCRIPTS 17. APPENDIX 1: TABULATED DATA 18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html You may also be interested in the following titles: Cannabis Testing Market Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities Cell Therapy Media Market, Cell Therapy Kits Market, Cell Therapy Reagents Market and Cell Therapy Surface Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #machinelearning #deeplearning #machinelearningalgorithms #Market Reseach #Market Insights

Deep Learning in Drug Discovery market Research Report by 2022, Forecast till 2035 The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost. This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning-based technologies / solutions within the healthcare industry. The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:  Therapeutic Area  Oncological Disorders  Infectious Diseases  Neurological Disorders  Immunological Disorders  Endocrine Disorders  Cardiovascular Disorders  Respiratory Disorders  Ophthalmic Disorders  Musculoskeletal Disorders  Inflammatory Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia Pacific  Rest of the World The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:  Aegicare  Aiforia Technologies  Ardigen  Berg  Google  Huawei  Merative  Nference  NVIDIA  Owkin  Phenomic AI  Pixel AI Table of Contents 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY 5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS 6. COMPANY PROFILES 7. PORTER’S FIVE FORCES ANALYSIS 8. CLINICAL TRIAL ANALYSIS 9. FUNDING AND INVESTMENT ANALYSIS 10. START-UP HEALTH INDEXING 11. COMPANY VALUATION ANALYSIS 12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY 13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS 14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS 15. CONCLUDING REMARKS 16. INTERVIEW TRANSCRIPTS 17. APPENDIX 1: TABULATED DATA 18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html You may also be interested in the following titles: Cannabis Testing Market Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities Cell Therapy Media Market, Cell Therapy Kits Market, Cell Therapy Reagents Market and Cell Therapy Surface Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #machinelearning #deeplearning #machinelearningalgorithms #Market Reseach #Market Insights

Cell Therapy Media market Research Report by 2022, Forecast till 2035 Roots Analysis has done a detailed study on Cell Therapy Media, Kits, Reagents and Surfaces Market, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. Key Market Insights  Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes  The market features the presence of more than 80 firms across the globe; majority of these stakeholders are emerging players based in North America  A larger proportion of the kits available in the cell therapy domain comprise of different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions  Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml  Predominantly, the cell therapy reagents are intended to be used at discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation  The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation  In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios  Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities  We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings  Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies  Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process; the pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their products  In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy consumables; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies  A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy consumables market at an annualized rate of 12%  The projected future opportunity for cell therapy consumable providers is expected to be well distributed across different types of end-users and key geographical regions Table of Contents 1. PREFACE 1.1. Introduction 1.2. Key Market Insights 1.3. Scope of the Report 1.4. Research Methodology 1.5. Frequently Asked Questions 1.6. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Context and Background 3.2. Introduction to Cell Therapies 3.3. Comparison of Cell Therapies with Other Biopharmaceuticals 3.4. Classification of Cell Therapy Products 3.5. Overview of Cell Therapy Development and Manufacturing 3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing 3.7. Types of Cell Therapy Consumables 3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables 3.9. Future Perspectives 4. MARKET LANDSCAPE 4.1. Chapter Overview 4.2. List of Cell Therapy Kit Providers 4.3. List of Cell Therapy Media Providers 4.4. List of Cell Therapy Reagent Providers 4.5. List of Cell Therapy Extracellular Matrix Providers 5. COMPANY COMPETITIVENESS ANALYSIS 5.1. Chapter Overview 5.2. Key Assumptions and Parameters 5.3. Methodology 5.4. Cell Therapy Consumables Providers: Company Competitiveness Analysis 5.5. Cell Therapy Kits Providers 5.6. Cell Therapy Media Providers 5.7. Cell Therapy Reagent Providers 5.8. Cell Therapy Extracellular Matrix Providers 6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS 6.1. Chapter Overview 6.2. Scope and Methodology 6.3. Brand Positioning: STEMCELL Technologies 6.4. Brand Positioning: Miltenyi Biotec 6.5. Brand Positioning: Thermo Fisher Scientific 6.6. Brand Positioning: Takara Bio 6.7. Brand Positioning: GeminiBio 7. COMPANY PROFILES 7.1. Chapter Overview 7.2. STEMCELL Technologies 7.2.1. Company Overview 7.2.2. Product Portfolio 7.2.3. Recent Developments and Future Outlook 7.3. Miltenyi Biotec 7.4. Thermo Fisher Scientific 7.5. Bio-Techne 7.6. Irvine Scientific 7.7. Lonza 7.8. Sartorius 7.9. BD Biosciences 7.10. Corning 7.11. CellGenix 8. RECENT DEVELOPMENTS AND INITIATIVES 8.1. Chapter Overview 8.2. Partnership Models 8.3. Cell Therapy Consumables: Partnerships and Collaborations 8.4. Cell Therapy Consumables: Mergers and Acquisitions 8.5. Cell Therapy Consumables: Recent Expansions 9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS 9.1. Chapter Overview 9.2. Scoring Criteria and Key Assumptions 9.3. Scope and Methodology 9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers 10. ROOTS ANALYSIS PRICING STRATEGY 10.1. Chapter Overview 10.2. Roots Analysis Framework 11. DEMAND ANALYSIS 11.1. Chapter Overview 11.2. Scope and Methodology 11.3. Global Demand for Cell Therapy Consumables 11.4. Analysis by Scale of Operation 11.5. Analysis by Geography 12. MARKET FORECAST AND OPPORTUNITY ANALYSIS 12.1. Chapter Overview 12.2. Key Assumptions and Methodology 12.3. Global Cell Therapy Consumables Market, 2023-2035 12.4. Cell Therapy Consumables Market: Analysis by Type of Product 12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy 12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation 12.7. Cell Therapy Consumables Market: Analysis by Type of End-User 12.8. Cell Therapy Consumables Market: Analysis by Geography 13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES 13.1. Chapter Overview 13.2. Emerging Trends Related to Cell Culture Media 13.3. Automation of Cell Therapy Manufacturing Processes 13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing 14. CONCLUDING REMARKS 15. INTERVIEW TRANSCRIPTS 16. APPENDIX I: TABULATED DATA 17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html You may also be interested in the following titles: Buffer Preparation Market Nanoparticle Formulation Market CAR-T cell therapy market cell and gene therapy CROs market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellTherapyMediaMarket #CellTherapyMediaMarketSize #consumables #consumablesproducts #cellcultureconsumables

Bioreactors and Fermenters market Research Report by 2022, Forecast till 2035 Bioreactors and fermenters play an indispensable role in the upstream biomanufacturing by providing requisite conditions for producing high-value products, including recombinant proteins, tissue engineered constructs and in vitro cell-based models Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Bioreactors and Fermenters Market, 2023-2035”. The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:  An executive summary of the insights captured during our research, offering a high-level view on the current state of the global bioreactors and fermenters market and its likely evolution in the mid-long term.  A general introduction to bioreactors and fermenters, along with details related to the components of a bioreactor. Additionally, the chapter presents information on different types of bioreactors based on type of bioprocess and mode of action. Further, it concludes with a discussion on applications of bioreactors and future perspectives in this domain.  A detailed assessment of the overall market landscape of companies manufacturing bioreactors and fermenters, based on several relevant parameters.  A detailed competitiveness analysis of bioreactor and fermenter manufacturers based on manufacturer strength and product portfolio strength.  Elaborate profiles of key players manufacturing bioreactors and fermenters (shortlisted based on their bioreactor and fermenter manufacturing capabilities).  An estimate of the global installed capacity of bioreactors and fermenters for biologics manufacturing, based on information provided by various industry stakeholders in the public domain.  A case study on the market landscape of bioprocess controllers and automation systems, providing information on several relevant parameters.  The financial opportunity within the global bioreactors and fermenters market has been analyzed across the following segments:  Type of Product  Bioreactors  Fermenters  Fabrication Material  Glass  Stainless Steel  Single-use  Type of Bioprocess  Batch and Fed-batch  Continuous  Type of Biologic  Antibodies  Vaccines  Cell Therapies  Other Biologics  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World Key companies covered in the report  Applikon Biotechnology  Bionet  Cytiva  Eppendorf  Merck  Ollital Technology  Parr Instrument Company  Sartorius  Shanghai Bailun Biological Technology  Solaris Biotech  Solida Biotech  Zhengzhou Laboao Instrument Equipment (LABAO) To view more details on this report, click on the link https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market Medical Device Coatings Market Smart Pharmaceutical and Healthcare Labels Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com bioreactors and fermenters, bioreactors and fermenters market, fermentation, fermentation bioreactors, bioreactors and fermenters market size

Medical Polymers market Growth Opportunity and Industry Forecast to 2035 Roots Analysis has done a detailed study on Pharmaceutical Polymers / Medical Polymers Market, 2023 – 2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. Key Market Insights  Currently, over 145 companies claim to manufacture various natural, semi-synthetic and synthetic pharmaceutical polymers; around 15% players develop more than three pharmaceutical polymer compositions  75% of the players claim to have the necessary expertise to produce thermoplastics; firms are primarily offering polymers for use in excipients, drug delivery and packaging  The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions  In pursuit of obtaining a competitive edge, industry stakeholders are actively upgrading their existing capabilities and adding new competencies to enhance their respective product portfolios  The number of partnerships inked in this domain demonstrates the growing interest of industry stakeholders; ~30% of the deals were inked for product development  DELT analysis focuses on monitoring the internal and external forces that may affect the strategic business of a company; further, it provides a consolidated view on the likely threats and opportunities within this domain  The pharmaceutical polymers / medical polymers market is likely to grow at a steady pace, till 2035; the projected opportunity is anticipated to be well distributed across types of polymers, area of applications and key regions Table of Contents 1. PREFACE 1.1. Introduction 1.2. Key Market Insights 1.3. Scope of the Report 1.4. Research Methodology 1.5. Frequently Asked Questions 1.6. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Chapter Overview 3.2. Overview of Polymers 3.3. Concluding Remarks 4. MARKET LANDSCAPE 4.1. Chapter Overview 4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape 5. COMPANY COMPETITIVENESS ANALYSIS 5.1. Chapter Overview 5.2. Assumptions and Key Parameters 5.3. Methodology 5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis 5.4.1. Company Competitiveness Analysis: Players based in North America 5.4.2. Company Competitiveness Analysis: Players based in Europe 5.4.3. Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World 6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA 6.1. Chapter Overview 6.2. Americhem 6.2.1. Company Overview 6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio 6.2.3. Recent Developments and Future Outlook 6.3. Celanese 6.3.1. Company Overview 6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio 6.3.3. Recent Developments and Future Outlook 6.4. Eastman 6.5. Lubrizol Life Science 6.6. LyondellBasell 7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE 7.1. Chapter Overview 7.2. Borealis 7.2.1. Company Overview 7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio 7.2.3. Recent Developments and Future Outlook 7.3. Henkel 7.4. KRAIBURG TPE 7.5. SEQENS 7.6. Solvay 8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD 8.1. Chapter Overview 8.2. Corel Pharma Chem 8.2.1. Company Overview 8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio 8.2.3. Recent Developments and Future Outlook 8.3. Kuraray 8.4. Phon Tech 8.5. Sumitomo Chemical 8.6. Zylog ElastoComp 9. PARTNERSHIPS AND COLLABORATIONS 9.1. Chapter Overview 9.2. Partnership Models 9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations 10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS 10.1. Chapter Overview 10.2. Key Parameters 10.3. Methodology 10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers 10.5. Concluding Remarks 11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS 11.1 Chapter Overview 11.2 Recent Trends Related to Pharmaceutical / Medical Polymers 11.3. Concluding Remarks 12. MARKET FORECAST AND OPPORTUNITY ANALYSIS 12.1. Chapter Overview 12.2. Key Assumptions and Forecast Methodology 12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035 13. CONCLUDING REMARKS 14. EXECUTIVE INSIGHTS 14.1. Chapter Overview 14.2. Cassion Biotech 14.3. Celares 14.4. Daikyo Seiko 15. APPENDIX 1: TABULATED DATA 16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/medical-polymers-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MedicalPolymersMarketGrowth #MedicalPolymersMarketTrends #medicalgradepolymer #pharmaceuticalpolymer #MedicalCo-polymer

Monkeypox Treatment market Research Report by 2022, Forecast till 2035 Roots Analysis has done a detailed study on Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. Key Market Insights  Presently, more than 25 therapeutics and vaccines are either marketed or under preclinical / clinical development for the treatment and prevention of monkeypox disease  Majority of the pipeline candidates are biologics, which are available in liquid dosage form; over 50% of the products are designed for oral administration  More than 165 diagnostic kits are currently available in the market for the detection of monkeypox virus; these kits utilize various detection methods for monkeypox diagnosis  Over 75% of the monkeypox diagnostic kits use polymerase chain reaction (PCR) as the detection method; more than 35% of such kits can detect the virus in less than 30 minutes  In pursuit of gaining a competitive edge, monkeypox diagnostic kit providers are presently undertaking initiatives to expand their existing capabilities and augment respective product portfolios  The growing interest in this domain is evident from the rise in partnership activity; in fact, the maximum number of collaborations related to monkeypox therapeutics and vaccines were inked in 2022  Grants worth over USD 250 million, disbursed across 270+ instances, have been awarded for research related to monkeypox; nearly 80% of these grants extend a support period of up to 10 years  The recent rise in number of scientific articles being published in this domain reflects the growing efforts of industry and academic stakeholders  Considering that the market for Mpox therapeutics / vaccines and diagnostics kits is currently very niche, featuring the presence of only a few players, the threat of new entrants is significant  The monkeypox therapeutics / vaccines market’s evolution is likely to be driven by the rising need for novel drug candidates; the market is anticipated to grow at a healthy pace in the foreseen future  The overall opportunity within monkeypox diagnostic kits market is anticipated to be well distributed across various types of kits, end users and key geographical regions Table of Contents 1. EXECUTIVE SUMMARY 2. INTRODUCTION 2.1. An Overview of Monkeypox 2.2. Signs and Symptoms 2.3. History of Disease Outbreaks 2.4. Disease Transmission 2.5. Disease Diagnosis 2.6. Prevention and Treatment 2.6.1. Prevention Measures 2.6.2. Available Therapeutics and Vaccines 2.7. Future Perspectives 3. MARKET LANDSCAPE: MONKEYPOX THERAPEUTICS AND VACCINES 3.1. Monkeypox Therapeutics and Vaccines: Overall Market Landscape 3.1.1. Analysis by Phase of Development 3.1.2. Analysis by Type of Product 3.1.3. Analysis by Phase of Development and Type of Product 3.1.4. Analysis by Type of Molecule 3.1.5. Analysis by Type of Dosage Form 3.1.6. Analysis by Route of Administration 3.2. Monkeypox Therapeutics and Vaccines: Developer Landscape 3.2.1. Analysis by Year of Establishment 3.2.2. Analysis by Type of Player 3.2.3. Analysis by Geography (Region-wise) 3.2.4. Analysis by Company Size and Geography (Region-wise) 3.2.5. Leading Developers: Analysis by Number of Therapeutics / Vaccines 4. MARKET LANDSCAPE: MONKEYPOX DIAGNOSTIC KITS 4.1. Monkeypox Diagnostic Kits: Overall Market Landscape 4.1.1. Analysis by Type of Sample 4.1.2. Analysis by Type of Kit Component 4.1.3. Analysis by Clade of Virus Detected 4.1.4. Analysis by Detection Method 4.1.5. Analysis by Application Area 4.1.6. Analysis by Type of Kit 4.1.7. Analysis by Quantity of Sample 4.1.8. Analysis by Turnaround Time 4.1.9 Analysis by Limit of Detection 4.1.10. Analysis by Number of Tests per Kit 4.1.11. Analysis by Shelf Life 4.1.12. Analysis by Storage Temperature 4.2 Monkeypox Diagnostic Kits: Developer Landscape 4.2.1. Analysis by Year of Establishment 4.2.2. Analysis by Company Size 4.2.3. Analysis by Location of Headquarters 4.2.4. Analysis by Company Size and Location of Headquarters 4.2.5. Analysis by Type of Developer 4.2.6. Key Developers: Analysis by Number of Diagnostic Kits Developed 5. MONKEYPOX DIAGNOSTIC KITS: PRODUCT COMPETITIVENESS ANALYSIS 5.1. Methodology 5.2. Product Competitiveness Analysis: Monkeypox Diagnostic Kits 6. COMPANY PROFILES: MONKEYPOX THERAPEUTICS AND VACCINES DEVELOPERS 6.1. Bavarian Nordic 6.1.1. Company Overview 6.1.2. Monkeypox Therapeutics / Vaccines Portfolio 6.1.3. Recent Developments and Future Outlook 6.2. Emergent BioSolutions 6.2.1. Company Overview 6.2.2. Monkeypox Therapeutics / Vaccines Portfolio 6.2.3. Recent Developments and Future Outlook 7. COMPANY PROFILES: MONKEYPOX DIAGNOSTIC KITS DEVELOPERS 7.1. ACON Laboratories 7.1.1. Company Overview 7.1.2. Monkeypox Diagnostic Kits Portfolio 7.2. altona Diagnostics 7.3. DNA Software 7.4. Elabscience 7.5. Goldsite Diagnostics 7.6. Hangzhou Testsea Biotechnology 7.7. Jiangsu Bioperfectus Technologies 7.8. Lansion Biotechnology 8. PARTNERSHIPS AND COLLABORATIONS 8.1. Monkeypox Therapeutics / Vaccines and Diagnostic Kits: Partnerships and Collaborations 8.1.1. Analysis by Year of Partnership 8.1.2. Analysis by Type of Partnership 8.1.3. Analysis by Year and Type of Partnership 8.1.4. Analysis by Focus Area 8.1.5. Analysis by Type of Partner 8.1.6. Most Active Players: Analysis by Number of Partnerships 8.1.7. Analysis by Local and International Agreements 8.1.8. Analysis by Intercontinental and Intracontinental Agreements 9. GRANTS ANALYSIS 9.1. Scope and Methodology 9.2. Key Parameters 9.3. Monkeypox Therapeutics / Vaccines and Diagnostic Kits: Grants Analysis 9.3.1. Analysis by Year of Grant Awarded 9.3.2. Analysis by Support Period 9.3.3. Analysis by Amount Awarded 9.3.4. Analysis by Leading Funding Institute Centre 9.3.5. Analysis by Type of Grant 9.3.6. Analysis by Activity Code 9.3.7. Analysis by Study Section Involved 9.3.8. Analysis by Purpose of Grant 9.3.9. Prominent Program Officers: Analysis by Number of Grants 9.3.10. Popular Recipient Organizations: Analysis by Number of Grants and Amount Awarded 9.3.11. Most Popular Departments: Analysis by Number of Grants 9.3.12. Analysis by Location of Recipient 10. PUBLICATION ANALYSIS 10.1. Methodology and Parameters 10.2. Monkeypox Therapeutics / Vaccines and Diagnostic Kits: Publication Analysis 10.2.1. Analysis by Year of Publication 10.2.2. Analysis by Type of Publication 10.2.3. Most Popular Journals: Analysis by Number of Publications 10.2.4. Most Popular Journals: Analysis by Journal Impact Factor 10.2.5. Popular Keywords: Analysis by Key Focus Areas 10.2.6. Most Active Publishers: Analysis by Number of Publications 10.2.7. Most Popular Affiliations: Analysis by Number of Publications 10.2.8. Analysis by Geography 11. PORTER’S FIVE FORCES ANALYSIS 11.1. Chapter Overview 11.2. Methodology and Key Parameters 11.3. Porter’s Five Forces 11.3.1. Threat of New Entrants 11.3.2. Bargaining Power of End Users 11.3.3. Bargaining Power of Drug Developers 11.3.4. Threat of Substitute Products 11.3.5. Rivalry Among Existing Competitors 12. MARKET FORECAST: MONKEYPOX THERAPEUTICS AND VACCINES 12.1. Chapter Overview 12.2. Key Assumptions and Forecast Methodology 12.3. Global Monkeypox Therapeutics and Vaccines Market, 2023-2035 12.3.1. Monkeypox Therapeutics and Vaccines Market: Analysis by Type of Product, 2023 and 2035 12.3.1.1. Monkeypox Therapeutics Market, 2023-2035 12.3.1.2. Monkeypox Vaccines Market, 2023-2035 12.3.2. Monkeypox Therapeutics and Vaccines Market: Analysis by Drug Developers, 2023 and 2035 12.3.2.1. Monkeypox Therapeutics and Vaccines Market for Bavarian Nordic, 2023-2035 12.3.2.2. Monkeypox Therapeutics and Vaccines Market for Emergent BioSolutions, 2023-2035 12.3.2.3. Monkeypox Therapeutics and Vaccines Market for KM Biologics, 2023-2035 12.3.2.4. Monkeypox Therapeutics and Vaccines Market for SIGA Technologies, 2023-2035 12.3.3. Monkeypox Therapeutics and Vaccines Market: Analysis by Drug Candidates, 2023 and 2035 12.3.3.1. IMVANEX® / JYNNEOS® / IMVAMUNER® (Bavarian Nordic): Sales Forecast, 2023-2035 12.3.3.2. ACAM2000 (Emergent BioSolutions): Sales Forecast, 2023-2035 12.3.3.3. VIGIV / CNJ-016 (Emergent BioSolutions): Sales Forecast, 2023-2035 12.3.3.4. LC16KMB (KM Biologics): Sales Forecast: Sales Forecast, 2023-2035 12.3.3.5. Tecovirimat / ST-246 / TPOXX (SIGA Technologies): Sales Forecast, 2023-2035 12.3.4. Monkeypox Therapeutics and Vaccines Market: Analysis by Geography, 2023 and 2035 12.3.4.1. Monkeypox Therapeutics and Vaccines Market in North America, 2023-2035 12.3.4.1.1. Monkeypox Therapeutics and Vaccines Market in the US, 2023-2035 12.3.4.1.2. Monkeypox Therapeutics and Vaccines Market in Canada, 2023-2035 12.3.4.2. Monkeypox Therapeutics and Vaccines Market in Europe, 2023-2035 12.3.4.2.1. Monkeypox Therapeutics and Vaccines Market in the UK, 2023-2035 12.3.4.2.2. Monkeypox Therapeutics and Vaccines Market in France, 2023-2035 12.3.4.2.3. Monkeypox Therapeutics and Vaccines Market in Germany, 2023-2035 12.3.4.2.4. Monkeypox Therapeutics and Vaccines Market in Spain, 2023-2035 12.3.4.2.5. Monkeypox Therapeutics and Vaccines Market in Italy, 2023-2035 13.3.4.2.6. Monkeypox Therapeutics and Vaccines Market in Rest of Europe, 2023-2035 12.3.4.3. Monkeypox Therapeutics and Vaccines Market in Asia Pacific, 2023-2035 12.3.4.3.1. Monkeypox Therapeutics and Vaccines Market in Japan, 2023-2035 12.3.4.3.2. Monkeypox Therapeutics and Vaccines Market in Australia, 2023-2035 13. MARKET FORECAST: MONKEYPOX DIAGNOSTIC KITS 13.1. Chapter Overview 13.2. Key Assumptions and Forecast Methodology 13.3. Global Monkeypox Diagnostic Kits Market, 2023-2035 13.3.1. Monkeypox Diagnostic Kits Market: Analysis by Type of Kit, 2023 and 2035 13.3.1.1. Monkeypox Polymerase Chain Reaction (PCR) Detection Kits Market, 2023-2035 13.3.1.2. Monkeypox Antigen Detection Kits Market, 2023-2035 13.3.1.3 Monkeypox Antibody Detection Kits Market, 2023-2035 13.3.2. Monkeypox Diagnostic Kits Market: Analysis by Type of End User, 2023 and 2035 13.3.2.1. Monkeypox Diagnostic Kits Market for Hospitals and Clinics, 2023-2035 13.3.2.2. Monkeypox Diagnostic Kits Market for Diagnostic Laboratories, 2023-2035 13.3.2.3. Monkeypox Diagnostic Kits Market for Other End Users, 2023-2035 13.3.3. Monkeypox Diagnostic Kits Market: Analysis by Geography, 2023 and 2035 13.3.3.1. Monkeypox Diagnostic Kits Market in North America, 2023-2035 13.3.3.1.1. Monkeypox Diagnostic Kits Market in the US, 2023-2035 13.3.3.1.2. Monkeypox Diagnostic Kits Market in Canada, 2023-2035 13.3.3.2. Monkeypox Diagnostic Kits Market in Europe, 2023-2035 13.3.3.2.1. Monkeypox Diagnostic Kits Market in the UK, 2023-2035 13.3.3.2.2. Monkeypox Diagnostic Kits in France, 2023-2035 13.3.3.2.3. Monkeypox Diagnostic Kits Market in Germany, 2023-2035 13.3.3.2.4. Monkeypox Diagnostic Kits Market in Spain, 2023-2035 13.3.3.2.5. Monkeypox Diagnostic Kits Market in Italy, 2023-2035 13.3.3.2.6. Monkeypox Diagnostic Kits Market in Rest of Europe, 2023-2035 13.3.3.3. Monkeypox Diagnostic Kits Market in Asia Pacific, 2023-2035 13.3.3.3.1. Monkeypox Diagnostic Kits Market in Japan, 2023-2035 13.3.3.3.2. Monkeypox Diagnostic Kits Market in Australia, 2023-2035 14. EXECUTIVE INSIGHTS 15. APPENDIX 1: TABULATED DATA 16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html You may also be interested in the following titles: Gene Switch Market Digital Biomanufacturing Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MonkeypoxTreatmentMarket #MonkeypoxTreatmentMarketGrowth #Monkeypox #mpox #Monkeypoxtreatment

Organ on a Chip market Analysis and Trends by 2022-2035 Roots Analysis has announced the addition of “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” report to its list of offerings. Key Market Insights  Presently, over 45 industry players claim to have the necessary capabilities to develop various organ-on-chip products and technologies, which can be used across different application areas  Based on the intellectual property distribution across the world, R&D activity related to organ-on-chip products and technologies, filed / granted by industry and non-industry players is significantly increasing in different geographical regions  In order to support the ongoing research for organ-on-chip models, 345+ grants worth more than USD 165 million have been awarded to various companies / organizations working in this domain till July 2022  The increased partnership activity related to organ-on-chip indicates a recent rise in the interest of players engaged in the development of organ-on-chip products and technologies  The significant amount was invested by both private and public investors in this domain, since 2017 for the research and development of organ-on-chip products and technologies  Case Study: Scaffold free 3D cell culture products that are developed / under development by both established and emerging players that can be used for biomedical testing  The projected opportunity for organ-on-chip is expected to grow at the CAGR of 21.3% and segmented across different types of product, application areas, types of purpose and key geographical regions Table of Content 1. PREFACE 1.1. Overview 1.2. Scope of the Report 1.3. Research Methodology 1.4. Key Questions Answered 1.5. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Chapter Overview 3.2. Background of Organ-on-Chip 3.3. Classification of Organ-on-Chip 3.4. Advantages and Limitations of Organ-on-Chip 3.5. Applications of Organ-on-Chip 3.6. Future Perspectives 4. ORGAN-ON-CHIP: MARKET LANDSCAPE 4.1. Chapter Overview 4.2. Organ-on-Chip: List of Products 4.3. Organ-on-Chip: Developer Landscape 5. ORGAN-ON-CHIP DEVELOPERS: COMPANY PROFILES 5.1. Chapter Overview 5.2. BEOnChip 5.2.1. Company Overview 5.2.2. Product Portfolio 5.2.3. Recent Developments and Future Outlook 5.3. Dynamic42 5.4. Emulate 5.5. Mimetas 5.6. SynVivo 5.7 TissUse 5.8 uFluidix 6. PATENT ANALYSIS 6.1. Chapter Overview 6.2. Scope and Methodology 6.3. Organ-on-Chip: Patent Analysis 6.4. Patent Benchmarking Analysis 6.5. Analysis by Patent Valuation 7. BRAND POSITIONING MATRIX 7.1. Chapter Overview 7.2 Methodology 7.3. Key Parameters 7.4. Companies Providing Organ-on-Chip 8. ACADEMIC GRANTS ANALYSIS 8.1 Chapter Overview 8.2. Scope and Methodology 8.3. Organ-on-Chip: Academic Grants Analysis 9. PARTNERSHIPS AND COLLABORATIONS 9.1. Chapter Overview 9.2. Partnership Models 9.3. Organ-on-Chip: List of Partnerships and Collaborations 10. FUNDING AND INVESTMENT ANALYSIS 10.1. Chapter Overview 10.2. Organ-on-Chip: List of Funding and Investments 11. CASE STUDY: SCAFFOLD-FREE 3D CELL CULTURE SYSTEMS 11.1. Chapter Overview 11.2. Scaffold-free Products: Market Landscape 11.3 . Scaffold Free Products: Developer Landscape 11.4 . Leading Developers: Analysis by Number of Scaffold Free Products 11.5 . Tree Map Representation: Analysis by Type of Product and Company Size 12. ORGAN-ON-CHIP: MARKET FORECAST AND OPPORTUNITY ANALYSIS 12.1. Chapter Overview 12.2. Forecast Methodology and Key Assumptions 12.3. Global Organ-on-Chip Market, 2022-2035 12.3.1. Global Organ-on-Chip Market, 2022-2035: Distribution by Type of Product 12.3.2. Global Organ-on-Chip Market, 2022-2035: Distribution by Application Area 12.3.3. Global Organ-on-Chip Market, 2022-2035: Distribution by Purpose 12.3.4. Global Organ-on-Chip Market, 2022-2035: Distribution by Key Geographical Regions 13. CONCLUSION 14. EXECUTIVE INSIGHTS 14.1. Chapter Overview 14.2. Cherry Biotech 14.2.1. Company Snapshot 14.2.2. Interview Transcript: Pierre Gaudriault, Chief Business Development Officer 14.3. EDmicBio 14.4. Hesperos 14.5. Lena Biosciences 14.6. react4life 14.7. Screenin3D 15. APPENDIX 1: TABULATED DATA 16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html You may also be interested in the following titles: Medical Device Coatings and Surface Modification Technologies Market mRNA Synthesis and Manufacturing Services Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #organonchipproductsandtechnologies #organonachipmodels #OrganonaChipmarket #OrganonaChipmarketsize

Bioavailability Enhancement Technologies and Services market Trends, Analysis by 2035 The bioavailability enhancement process is known to be fraught with several challenges, including its time and cost intensive nature; given the expertise available with service providers to improve pharmacokinetic properties of novel molecules, developers are actively outsourcing their requirements The financial opportunity within the bioavailability enhancement services market has been analyzed across the following segments:  Drug Class  New Drug Approvals  Generics  BCS Classification  BCS II Drugs  BCS IV Drugs  Bioavailability Enhancement Approach  Solid Dispersion  Size Reduction  Lipid-based  Dosage Form  Liquids  Solids  Semi-Solids  Fine Particles / Powders  Key Geographies  North America  Europe  Asia  Latin America  Middle East and North Africa (MENA)  Rest of the World The Bioavailability Enhancement Technologies and Services Market (2nd Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:  Adare Pharma Solutions  Ascendia Pharmaceuticals  Catalent  Lonza  Lubrizol Life Science Health  Pace Life Sciences  Quotient Sciences  WuXi STA (a subsidiary of WuXi AppTec) Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Bioavailability Enhancement Service Providers 5. Market Landscape: Bioavailability Enhancement Technology Providers 6. Key Insights 7. Company Profiles 8. Company Benchmark Analysis 9. Partnerships and Collaborations 10. Publication Analysis 11. Patent Analysis 12. Clinical Trial Analysis 13. Technology Evaluation Framework 14. Demand Analysis 15. Market Forecast and Opportunity Analysis 16. Conclusion 17. Appendix 1: List of Companies 18. Appendix 2: Tabulated Data To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html You may also be interested in the following titles: Genotoxicity Testing and Mutagenicity Testing Services Market DNA Encoded Libraries About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #bioavailabilityenhancement #bioavailabilityenhancementtechniques #activepharmaceuticalingredient

Medical Device Coatings market Professional Survey Report by 2035 The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices. Presently, multiple types of medical device coatings are available in the market to accommodate the multifunctionality of novel medical devices. A detailed medical device coating market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Devices Coated  Class I Medical Devices  Class II Medical Devices  Class III Medical Devices  Type of Coating Material  Polymer Coatings  Metal Coatings  Other Coatings  Company Size  Very Small  Small  Mid-sized  Large  Very Large  Key Geographical Region  North America  Europe  Asia  Rest of the World Key companies covered in the report  Advanced Coating  Biocoat  Evonik  Formacoat  Harland Medical Systems  Para-Coat Technologies  Specialty Coating Systems  SurModics  TUA Systems Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Medical Device Coating Providers: Market Landscape 5. Company Competitiveness Analysis 6. Surface Modification Technologies and Coating Solutions: Market Landscape 7. Product Competitiveness Analysis 8. Medical Device Coating Providers: Company Profiles 9. Partnerships and Collaborations 10. Medical Device Coating Providers: Pestle Analysis 11. Market Forecast 12. Concluding Remarks 13. Executive Insights 14. Appendix 1: Tabulated Data 15. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/medical-device-coatings-market.html You may also be interested in the following titles: mRNA Synthesis and Manufacturing Services Market Lab Automation Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MedicalDeviceCoatingsmarket #MedicalDeviceCoatingsmarketGrowth #MedicalDeviceCoatings #antimicrobialcoatingsformedicaldevices #surfacetreatmenttechnologies

Quantum Computing market Share, Growth Analysis by 2035 The “Quantum Computing in Drug Discovery Services Market, 2023-2035” report features an extensive study of the current landscape and the likely future potential over the next decade Key Inclusions  A general overview of quantum computing in drug discovery services, along with information on its types and applications across various industries. It also highlights the applications of quantum computing, specifically related to drug discovery. Further, the chapter features a discussion on the challenges, key growth drivers, and future perspectives.  A detailed assessment of the overall market landscape of quantum computing software providers, based on several relevant parameters, including year of establishment, company size (in terms of number of employees), location of headquarters, business capabilities (platform / software, quantum as a service, drug discovery service and in-house pipeline), platform capabilities (drug discovery, drug design, supply chain management and drug development(clinical trials)), type of drug discovery service(s) offered (target discovery / identification, target validation / selection, hit generation / identification / discovery, hit to lead / hit expansion / target to lead / lead identification / select lead series and lead optimization), type of molecule(s) supported (small molecules and large molecules), compatible computational approaches (artificial intelligence and cloud computing), end user(s) (pharmaceutical companies, contract research organizations and academic / research institutes) and therapeutic area(s) (cardiovascular disorders, infectious diseases, neurological disorders , oncological disorders and others)  A detailed competitiveness analysis of quantum computing service providers based on company strength (in terms of years of experience), portfolio strength (in terms of type of drug discovery services offered, type of molecule(s) supported, type of computational approaches and type of end-user(s)), and portfolio diversity (in terms of business capabilities).  Elaborate profiles of quantum computing software providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.  A detailed assessment of the overall market landscape of quantum computing hardware providers, based on several parameters including year of establishment, company size (in terms of number of employees), location of headquarters, type of offering(s) (hardware as a service and hardware for purchase), data storage on cloud and compatible computational approaches (artificial intelligence and cloud computing)  Detailed profiles of quantum computing hardware providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.  A detailed review of over 170 academic grants focused on quantum computing in drug discovery, based on several relevant parameters, such as year of grants awarded, amount awarded, support period, type of study section, administering institute center, type of grant, activity code, funding mechanism and amount granted, funding institute and support period, prominent program officers (by number of grants), location of recipient organizations, popular recipient organizations, organization type and amount granted to popular recipient.  A detailed analysis of recent partnerships inked between stakeholders engaged in this domain, since 2017, based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships), and regional distribution of partnership activity in this domain.  A use case study highlighting the applications of quantum computing across various industries, such as chemical industry, cybersecurity, financial modeling, space sciences, oil and gas industry and weather forecasting, and its likely evolution in the foreseen future.  A qualitative analysis, highlighting the five competitive forces prevalent in this domain, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute product and rivalry among existing competitors.  A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software providers to shift towards a blue ocean strategic market.  One of the key objectives of the report was to estimate the current opportunity and future growth potential of quantum computing in drug discovery services market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as drug discovery services offered (target identification / validation, hit generation / lead identification and lead optimization), therapeutic area (cardiovascular disorders, CNS disorders, dermatological disorders, endocrine disorders, gastrointestinal disorders, immunological disorders, infectious diseases, musculoskeletal disorders, oncological disorders, respiratory disorders and others), and key geographical regions ((North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution. By 2035, the financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:  Drug Discovery Service(s) Offered  Target Identification / Validation  Hit Generation / Lead Identification  Lead Optimization  Therapeutic Area  Cardiovascular Disorders  CNS Disorders  Dermatological Disorders  Endocrine Disorders  Gastrointestinal Disorders  Immunological Disorders  Infectious Diseases  Musculoskeletal Disorders  Oncological Disorders  Respiratory Disorders  Others  Geographical Regions  North America  Europe  Asia-Pacific  Latin America  MENA Key Questions Answered  What is quantum computing and how does it work in drug discovery?  What is the current market landscape of the quantum computing market focused on drug discovery?  What are the key trends across grants awarded for quantum computing in drug discovery?  What are the key trends in the partnerships and collaborations for quantum computing in drug discovery?  What is the impact of quantum computing on the pharmaceutical industry?  What is the market size of quantum computing in drug discovery services market?  Who are the players in the quantum computing in drug discovery services market? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #QuantumComputingMarket #QuantumComputingMarketSize #quantumcomputinginhealthcare #quantumcomputingindrugdiscovery #quantumcomputing